Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?

Crit Care Med. 2009 Apr;37(4):1486-7. doi: 10.1097/CCM.0b013e31819d2bb4.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anticoagulants / administration & dosage*
  • Heparin / administration & dosage*
  • Humans
  • Partial Thromboplastin Time*
  • Shock, Septic / blood*
  • Shock, Septic / drug therapy*

Substances

  • Anticoagulants
  • Heparin